1,703 results on '"Döhner, Konstanze"'
Search Results
2. FRACTION: protocol of a phase II study of Fedratinib and Nivolumab combination in patients with myelofibrosis and resistance or suboptimal response to JAK-inhibitor treatment of the German MPN study group (GSG-MPN)
3. ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options
4. Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts
5. Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients
6. Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing induction regimen
7. Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease
8. Validation of myeloproliferative neoplasms associated risk factor RDW as predictor of thromboembolic complications in healthy individuals: analysis on 6849 participants of the SHIP-study
9. Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurin
10. In vivo kinetics of early, non-random methylome and transcriptome changes induced by DNA-hypomethylating treatment in primary AML blasts
11. Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN)
12. AML with complex karyotype: extreme genomic complexity revealed by combined long-read sequencing and Hi-C technology
13. Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study
14. Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group
15. First-in-human study of WT1 recombinant protein vaccination in elderly patients with AML in remission: a single-center experience
16. Correction: Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients
17. Netboost: Boosting-supported network analysis improves high-dimensional omics prediction in acute myeloid leukemia and Huntington's disease
18. Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09–09): a randomised, open-label, multicentre, phase 3 trial
19. Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial
20. UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment
21. Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications
22. Longitudinal single-cell transcriptomics reveals distinct patterns of recurrence in acute myeloid leukemia
23. Unified classification and risk-stratification in Acute Myeloid Leukemia
24. Continued decitabine/all-trans retinoic acid treatment: extended complete remission in an elderly AML patient with multi-hit TP53 lesions and complex-monosomal karyotype.
25. PLCG1 is required for AML1-ETO leukemia stem cell self-renewal
26. Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results
27. Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial
28. Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations
29. Deregulated expression of circular RNAs in acute myeloid leukemia
30. Proposals for revised International Working Group–European LeukemiaNet criteria for anemia response in myelofibrosis
31. Germline variants drive myelodysplastic syndrome in young adults
32. Genetic alterations in Thai adult patients with acute myeloid leukemia and myelodysplastic syndrome—excess blasts detected by next-generation sequencing technique
33. Activating JAK-mutations confer resistance to FLT3 kinase inhibitors in FLT3-ITD positive AML in vitro and in vivo
34. Genomic characterization of AML with aberrations of chromosome 7:a multinational cohort of 519 patients
35. Precision hematology:Navigating the evolution of diagnostic classifications in the era of globalized medicine
36. Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial
37. Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implication
38. Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial
39. Wer ist ... Konstanze Döhner?
40. TET1 promotes growth of T-cell acute lymphoblastic leukemia and can be antagonized via PARP inhibition
41. Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia
42. Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study
43. MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells
44. Differences in expression and function of LEF1 isoforms in normal versus leukemic hematopoiesis
45. Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML)
46. Functional characterization of BRCC3 mutations in acute myeloid leukemia with t(8;21)(q22;q22.1)
47. Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia
48. The ParaHox gene Cdx4 induces acute erythroid leukemia in mice
49. Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group
50. Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.